Role of Acute Graft-Versus-Host Disease in the Risk of Bacteremia and Invasive Fungal Disease after Allogeneic Hemopoietic Stem Cell Transplantation in Children. Results from a Single-Center Observational Study

被引:21
|
作者
Castagnola, Elio [1 ]
Bagnasco, Francesca [2 ]
Bandettini, Roberto [3 ]
Caviglia, Ilaria [1 ]
Morreale, Giuseppe [4 ]
Lanino, Edoardo [4 ]
Giardino, Stefano [4 ]
Moroni, Cristina [1 ]
Haupt, Riccardo [2 ]
Faraci, Maura [4 ]
机构
[1] Ist Giannina Gaslini, Infect Dis Unit, I-16147 Genoa, Italy
[2] Ist Giannina Gaslini, Epidemiol Biostat & Comm Unit, I-16147 Genoa, Italy
[3] Ist Giannina Gaslini, Lab Anal, I-16147 Genoa, Italy
[4] Ist Giannina Gaslini, Dept Haematol Oncol, HSCT Unit, I-16147 Genoa, Italy
关键词
Acute graft-versus-host disease; Bacteremia; Invasive fungal disease; Allogeneic hemopoietic stem; cell transplantation; Children; INFECTIOUS COMPLICATIONS; EPIDEMIOLOGY; BLOOD; NEUTROPENIA; RECIPIENTS; MYCOSES; 1ST;
D O I
10.1016/j.bbmt.2014.03.026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Data on epidemiology of severe infectious complications, ie, bacteremia or invasive fungal disease (IFD), in children with acute graft-versus-host disease (aGVHD) after allogeneic hemopoietic stem cell transplantation (HSCT) are scarce. In a retrospective, single-center study, we analyzed the risk (hazard ratio [HR]) and the rate (episodes/1000 patients days at risk) of bacteremias and IFD in children receiving allogeneic HSCT, according to the type of donor (matched related [MRD] or alternative [AD]) and presence and grade of aGVHD. From 2000 to 2009, 198 children receiving 217 allogeneic HSCT developed 134 severe infectious episodes (103 bacteremias and 31 IFD). The type of donor (AD versus MRD) was the most important risk factor for the severe infections (P =.0052). In separate multivariable analysis for bacteremia and IFD, children receiving an AD HSCT had increased HR and rate of bacteremia compared with those receiving a MRD transplantation (P =.0171 and P =.0001, respectively), whereas the HR and the rate of IFD were significantly influenced by the grade of aGVHD (P =.0002 and P <.0001, respectively). Finally, infectious episodes occurred late after HSCT, especially in presence of severe aGVHD, and bacteremias were 3 to 6 times more frequent than IFD. These data may be important to design management strategies of infections in pediatric allogeneic HSCT. (C) 2014 American Society for Blood and Marrow Transplantation.
引用
收藏
页码:1068 / 1073
页数:6
相关论文
共 50 条
  • [41] Chronic graft-versus-host disease after allogeneic blood stem cell transplantation
    Przepiorka, D
    Anderlini, P
    Saliba, R
    Cleary, K
    Mehra, R
    Khouri, I
    Huh, YO
    Giralt, S
    Braunschweig, I
    van Besien, K
    Champlin, R
    BLOOD, 2001, 98 (06) : 1695 - 1700
  • [42] Is there an increased risk of graft-versus-host disease after allogeneic peripheral blood stem cell transplantation?
    Koc, H
    Gurman, G
    Arslan, O
    Ozcan, M
    Akan, H
    Ilhan, O
    Konuk, N
    Beksac, M
    Uysal, A
    BLOOD, 1996, 88 (06) : 2362 - 2364
  • [43] Chronic graft-versus-host disease is a risk factor for hyposplenism after allogeneic stem cell transplantation
    Martinez, M. T.
    Rovo, A.
    Baldomero, H.
    Halter, J.
    Gerull, S.
    Lehmann, T.
    Passweg, J. R.
    Tichelli, A.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S347 - S348
  • [44] Diarrhea after allogeneic stem cell transplantation: beyond graft-versus-host disease
    Robak, Katarzyna
    Zambonelli, Joanna
    Bilinski, Jaroslaw
    Basak, Grzegorz W.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (05) : 495 - 502
  • [45] Increased Incidence of Hypogammaglobulinemia in Patients with Acute Graft-versus-Host Disease after Allogeneic stem cell transplantation - A single center retrospective analysis
    Limvorapitak, Wasithep
    Abou Mourad, Yasser
    Barnett, Michael
    Broady, Raewyn
    Forrest, Donna
    Gerrie, Alina
    Hogge, Donna
    Nantel, Stephen
    Narayanan, Sujaatha
    Nevill, Thomas
    Sanford, David
    Song, Kevin
    Sutherland, Heather
    Toze, Cynthia
    White, Jennifer
    Power, Maryse
    BONE MARROW TRANSPLANTATION, 2018, 53 : 563 - 564
  • [46] Cytokine trajectories and risk of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation
    Gjaerde, L. K.
    Zucco, A. G.
    von Stemann, J. H.
    Minculescu, L.
    Moller, J. A.
    Brooks, P. T.
    Hansen, M. B.
    Reekie, J.
    Ostrowski, S. R.
    Sengelov, H.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 200 - 201
  • [47] Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease
    Miller, Holly K.
    Braun, Thomas M.
    Stillwell, Terri
    Harris, Andrew C.
    Choi, Sung
    Connelly, James
    Couriel, Daniel
    Goldstein, Steven
    Kitko, Carrie L.
    Magenau, John
    Pawarode, Attaphol
    Reddy, Pavan
    Riwes, Mary
    Yanik, Gregory A.
    Levine, John E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : 522 - 528
  • [48] Graft-versus-Host Disease after Liver Transplantation: A Single-Center Case Series
    Elsiesy, Hussien
    Ibrahim, Abeer
    Selim, Khaled
    Al Sebayel, Mohammed
    Broering, Dieter
    Al Hamoudi, Waleed
    Al Arieh, Rania
    Abaalkhail, Faisal
    ANNALS OF TRANSPLANTATION, 2015, 20 : 397 - 401
  • [49] Gut decontamination during allogeneic hematopoietic stem cell transplantation and the risk of acute graft-versus-host disease
    Gjaerde, Lars K.
    Schmidt, Mette
    Sengelov, Henrik
    BONE MARROW TRANSPLANTATION, 2018, 53 (08) : 1061 - 1064
  • [50] Clinical impact of hyperacute graft-versus-host disease on results of allogeneic stem cell transplantation
    Kim, DH
    Sohn, SK
    Kim, JG
    Suh, JS
    Lee, KS
    Lee, KB
    BONE MARROW TRANSPLANTATION, 2004, 33 (10) : 1025 - 1030